Comparison of renal effects of ibuprofen versus indomethacin during treatment of patent ductus arteriosus in contiguous historical cohorts

Alla Kushnir,Joaquim Mb Pinheiro

doi:10.1186/1472-6904-11-8

Alla Kushnir, Joaquim Mb Pinheiro

Open Access

https://doi.org/10.1186/1472-6904-11-8

Copy DOI

Abstract

BackgroundIbuprofen treatment of patent ductus arteriosus (PDA) has been shown to be as effective as indomethacin in small randomized controlled trials, with possibly fewer adverse effects. However, adverse renal effects of ibuprofen have been noted in some trials and suspected in our practice.The purpose of this study was to examine whether ibuprofen and indomethacin treatment of PDA have comparable effects on renal function as evidenced by urine output and serum creatinine.MethodsRetrospective chart review of 350 patients. Serum creatinine and urine output were recorded prior to start of treatment, during each course and after the last course of treatment. Pre-treatment mean creatinine and urine output values were compared to treatment and post treatment means using 2-factor repeated measures ANOVA.Results165 patients were treated with indomethacin (2005-2006) and 185 received ibuprofen (2007-2008). There was no difference between treatment groups in demographics or baseline renal function. For both groups, the number of treatment courses was inversely correlated with birth weight and gestational age. Analysis of the first course including all patients, revealed significant increase in creatinine and decrease in urine output with both drugs, with a more pronounced effect of indomethacin on creatinine. In the subgroup of 219 patients who received only one treatment course, there was a significant increase in creatinine after indomethacin, but not after ibuprofen. In the 131 who received 2 or more courses, the decrease in urine output and increase in creatinine were not different between drugs. There were significant decreases in urine output observed in the second and third courses of ibuprofen treatment (both by 0.9 mL/kg/hr).ConclusionBoth drugs have a similar short-term effect on renal function. Indomethacin had a more prominent initial effect, while ibuprofen decreased renal function during the second and third courses similarly to indomethacin. The changes in renal function seen with ibuprofen treatment should be considered in fluid and electrolyte management, especially if treatment beyond one course is required.

Highlights

Ibuprofen treatment of patent ductus arteriosus (PDA) has been shown to be as effective as indomethacin in small randomized controlled trials, with possibly fewer adverse effects
Adverse effects of ibuprofen have been noted in some trials [16] and suspected in our practice. This difference might be due to the fact that the infants in the previous trials were more mature than the age of the infants at greatest risk for PDA; it is difficult to extrapolate the clinical effects observed in those trials to the younger and unselected population typically treated in the clinical care context
The purpose of this study was to examine whether ibuprofen and indomethacin treatment of PDA have comparable effects on renal function as typically used in a NICU, where it is common for ELBW neonates to receive more than one course of cyclooxygenase inhibitor therapy in order to close the PDA

Summary

Introduction

Ibuprofen treatment of patent ductus arteriosus (PDA) has been shown to be as effective as indomethacin in small randomized controlled trials, with possibly fewer adverse effects. Indomethacin may lead to complications such as transient or permanent renal dysfunction [8,9], necrotizing enterocolitis, and reduced cerebral oxygenation [10] These indomethacin-related complications have prompted researchers to seek safer pharmacological treatment for closure of PDA. In recent years another cyclooxygenase inhibitor, ibuprofen, has been proposed for the treatment of PDA, and several randomized controlled trials have shown it to be as efficacious as indomethacin, with possibly fewer adverse effects [11]. Our primary objective was to ascertain whether ibuprofen and indomethacin treatment of PDA have comparable effects on renal function as evidenced by urine output and serum creatinine, during routine clinical usage

Objectives

Methods

Results

Discussion

Conclusion